范围 | 局部内昔芬 | 口服内昔芬 |
---|---|---|
Safety | There were no reported significant adverse safety events | 没有临床上明显的安全信号,并且在接受口服内昔芬的参与者中没有临床明显的不良事件 |
Tolerability | 研究受试者可以很好地耐受剂量水平的局部昔夫蛋白的剂量水平和剂量持续时间 | 口服内昔芬在每个剂量水平和研究中使用的剂量持续时间都得到很好的耐受性 |
药代动力学 | Higher levels of endoxifen was achieved in the blood of subject who received higher doses of the topical drug | 口服内昔芬表现出与乳腺癌女性辅助环境中治疗作用有关的血液水平 |